Front Page

Previous Story

Next Story

NIH Record vertical blue bar column separator

New Appointments graphic

Okita Joins NIGMS

Dr. Richard Okita recently joined NIGMS as a program director in the Division of Pharmacology, Physiology, and Biological Chemistry, where he will administer grants in the areas of drug metabolism, transporters, eicosanoids, pharmacokinetics, toxicology, drug delivery, and formulations. He will also manage the institute's clinical pharmacology training grant awards. Okita comes to NIGMS from Washington State University in Pullman, where he was associate chair of the department of pharmaceutical sciences in the College of Pharmacy and a professor of pharmaceutical sciences. His research interests focused on the cytochrome P-450 monooxygenase system — a superfamily of proteins involved in the metabolism of both exogenous and endogenous compounds including drugs, carcinogens, steroids and fatty acids. He is a member of various professional societies, including the American Society for Pharmacology and Experimental Therapeutics, where he was elected to serve as chair of the society's division for drug metabolism in 2001.

Greenwel Is New SRA at CSR

Dr. Patricia Greenwel has joined the Center for Scientific Review as scientific review administrator for the alcohol and toxicology subcommittee-1 scientific review group. This group reviews applications for grants to study the cellular and subcellular effects of toxicants and alcohol. She received an M.S. and a Ph.D. in experimental pathology from Albert Einstein College of Medicine, where she showed that interleukin-6 accelerates liver cirrhosis (scarring of the liver). This discovery has clinical relevance for individuals afflicted with liver cirrhosis. During her postdoctoral training at Mount Sinai School of Medicine in New York City, she showed how type I collagen, the major scar component produced during liver cirrhosis, is regulated at the genetic level.


Up to Top